AUTOLOGOUS TRANSPLANTATION (AT) OF CD34-BLOOD PROGENITOR CELLS (PBPC)AFTER DOUBLE (D) HIGH-DOSE CHEMOTHERAPY (HDC) IN MULTIPLE-MYELOMA (MM) IS FOLLOWED BY SEVERE IMMUNODEFICIENCY (ID) AND HIGH PRODUCTION OF INTERLEUKIN-6 (IL-6) RELATED-C REACTIVE PROTEIN (CRP) REQUIRING ADDITIVE IMMUNOTHERAPY (IT)( PERIPHERAL)
Jf. Rossi et al., AUTOLOGOUS TRANSPLANTATION (AT) OF CD34-BLOOD PROGENITOR CELLS (PBPC)AFTER DOUBLE (D) HIGH-DOSE CHEMOTHERAPY (HDC) IN MULTIPLE-MYELOMA (MM) IS FOLLOWED BY SEVERE IMMUNODEFICIENCY (ID) AND HIGH PRODUCTION OF INTERLEUKIN-6 (IL-6) RELATED-C REACTIVE PROTEIN (CRP) REQUIRING ADDITIVE IMMUNOTHERAPY (IT)( PERIPHERAL), Blood, 88(10), 1996, pp. 516-516